| | | | | Experimental host and age | Passage history and strain | Inoculation Route-Dose | Evidence of infection | AST (days) | Titer log10/ml | |
|---|
|
| | Mice (nb) | SMB 3 | ic 0.01 | Paralysis, death (9,22-24) | 6 | 7.8 | | | Mice (nb) | | ip 0.03 | Paralysis, death (9,22-24) | 12 | 2.6 | | | Mice (nb) | | sc | | | | | | Mice (wn) | | ic 0.03 | No symptoms (9,22-24) | | | | | Mice (wn) | | ip 0.1 | Antibody production (9,22-24) | | | | | Apodemus flavicollis | | ic, sc | No viremia; isolations from organs (14) | | | | | Microtus arvalis (nb) | | ic | Death (14) | 5-8 | 7.0 | | | Chlethrionomys glareolus (ad) | | ic | No viremia; isolations from organs (14) | | | | | guinea pig (2 mo) | | | Antibody formation | | | | | chicken (6 day) | | sc | Viremia, antibody formation (9) | | 3.6 | | | embryonated egg (6-11 day) | | CAM, ys | Death, CAM inflamm.(22) | 3-6 | 7.5 (yolk) | | | rhesus monkey | | ic | Viremia, meningeal symptoms (25) | | | | | rhesus monkey | | ip | Viremia | | 7.0 | | | | | | | | | |
| | |
|
